Galectin Therapeutics Inc.’s GALT share price has dipped by 5.07%, which has investors questioning if this is right time to ...

The mechanistic basis for spreading ferroptosis to neighboring cells remains unclear. Galectin-13, a secreted galectin, is now identified as a pivotal mediator of ferroptosis propagation and a ...

Galectin-13, a secreted galectin ... A near-infrared optogenetic system was developed for the controlled expression of therapeutics in engineered oncolytic bacteria, demonstrating significant ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the ...

Discover the latest drugs and treatment options in the Psoriasis Pipeline. Dive into DelveInsight's comprehensive report today! @ Psoriasis Pipeline Outlook In April 2025, Alumis Inc. announced a ...

Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) – HC Wainwright lifted their Q2 2025 earnings per share (EPS) estimates for shares of Galectin Therapeutics in a research note issued to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Here is how ANI Pharmaceuticals (ANIP) and Galectin Therapeutics Inc. (GALT) have performed compared to their sector so far this year.

One other Medical stock that has outperformed the sector so far this year is Galectin Therapeutics Inc. (GALT). The stock is up 2.3% year-to-date. Over the past three months, Galectin Therapeutics ...

NORCROSS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results ...

NORCROSS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (GALT) (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial ...